This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is characteristic of a monopolistically competitive firm? a. The firm faces ... (Read 35 times)

soccerdreamer_17

  • Hero Member
  • *****
  • Posts: 552
Which of the following is characteristic of a monopolistically competitive firm?
 a. The firm faces an upward-sloping demand curve.
  b. The firm faces an inelastic demand curve.
  c. The firm faces a horizontal demand curve.
  d. The firm produces a differentiated product.

Question 2

The absolute value of the slope of an indifference curve is called the:
 a. marginal rate of transformation.
  b. transitivity slope.
  c. indifference rate of preference.
  d. marginal rate of substitution.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sabina576

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

d

Answer to Question 2

d




soccerdreamer_17

  • Member
  • Posts: 552
Reply 2 on: Jun 30, 2018
Excellent


peter

  • Member
  • Posts: 330
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library